ABSTRACT
Shaping an epidemic with an adaptive contact restriction policy that balances the disease and socioeconomic impact has been the holy grail during the COVID-19 pandemic. Most of the existing work on epidemiological models focuses on scenario-based forecasting via simulation but techniques for explicit control of epidemics via an analytical framework are largely missing. In this paper, we consider the problem of determining the optimal control policy for transmission rate assuming SIR dynamics, which is the most widely used epidemiological paradigm. We first demonstrate that the SIR model with infectious patients and susceptible contacts (i.e., product of transmission rate and susceptible population) interpreted as predators and prey respectively reduces to a Lotka-Volterra (LV) predator-prey model. The modified SIR system (LVSIR) has a stable equilibrium point, an “energy” conservation property, and exhibits bounded cyclic behaviour similar to an LV system. This mapping permits a theoretical analysis of the control problem supporting some of the recent simulation-based studies that point to the benefits of periodic interventions. We use a control-Lyapunov approach to design adaptive control policies (CoSIR) to nudge the SIR model to the desired equilibrium that permits ready extensions to richer compartmental models. We also describe a practical implementation of this transmission control method by approximating the ideal control with a finite, but a time-varying set of restriction levels. We provide experimental results comparing with periodic lockdowns on few different geographical regions (India, Mexico, Netherlands) to demonstrate the efficacy of this approach.
CCS CONCEPTS •Applied computing → Life and medical sciences; • Computing methodologies → Control methods.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Our work does not involve clinical trials
Funding Statement
No external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No special approvals were required for this work.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
harsh.maheshwari{at}flipkart.com
shreyas.shetty{at}flipkart.com
nayana.bannur{at}wadhwaniai.org
srujana{at}gmail.com
Added experiment results to show the efficacy of the proposed algorithm when compared against other popular algorithms like Periodic Lockdown. The experiments were done on three regions - India, Netherlands and Mexico.
4 Since these estimations vary, we choose an intermediate value.
↵5 Note that J, I are actually discrete population counts and not continuous functions.
Data Availability
All data used for our experiments are publicly available. Data sources include, (i)Public Health England COVID-19 data (ii)Covid19india data (iii)The New York Times COVID-19 data
https://data.london.gov.uk/dataset/coronavirus--covid-19--cases